BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 24374203)

  • 1. Bone marrow mesenchymal stromal cells rescue cardiac function in streptozotocin-induced diabetic rats.
    Monnerat-Cahli G; Trentin-Sonoda M; Guerra B; Manso G; Ferreira AC; Silva DL; Coutinho DC; Carneiro-Ramos MS; Rodrigues DC; Cabral-da-Silva MC; Goldenberg RC; Nascimento JH; Campos de Carvalho AC; Medei E
    Int J Cardiol; 2014 Feb; 171(2):199-208. PubMed ID: 24374203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone-Marrow-Derived Mesenchymal Stromal Cells (MSC) from Diabetic and Nondiabetic Rats Have Similar Therapeutic Potentials.
    José VSS; Monnerat G; Guerra B; Paredes BD; Kasai-Brunswick TH; Carvalho ACC; Medei E
    Arq Bras Cardiol; 2017 Dec; 109(6):579-589. PubMed ID: 29364350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of different pancreatic microenvironments on improvement in hyperglycemia and insulin deficiency in diabetic rats after transplantation of allogeneic mesenchymal stromal cells.
    Katuchova J; Tothova T; Farkasova Iannaccone S; Toporcer T; Harvanova D; Hildebrand T; Kilik R; Bacenkova D; Frohlichova L; Rosocha J; Bobrov N; Radonak J
    J Surg Res; 2012 Nov; 178(1):188-95. PubMed ID: 22480834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple intravenous infusions of bone marrow mesenchymal stem cells reverse hyperglycemia in experimental type 2 diabetes rats.
    Hao H; Liu J; Shen J; Zhao Y; Liu H; Hou Q; Tong C; Ti D; Dong L; Cheng Y; Mu Y; Liu J; Fu X; Han W
    Biochem Biophys Res Commun; 2013 Jul; 436(3):418-23. PubMed ID: 23770360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic administration of multipotent mesenchymal stromal cells reverts hyperglycemia and prevents nephropathy in type 1 diabetic mice.
    Ezquer FE; Ezquer ME; Parrau DB; Carpio D; Yañez AJ; Conget PA
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):631-40. PubMed ID: 18489988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal stem cells ameliorate podocyte injury and proteinuria in a type 1 diabetic nephropathy rat model.
    Wang S; Li Y; Zhao J; Zhang J; Huang Y
    Biol Blood Marrow Transplant; 2013 Apr; 19(4):538-46. PubMed ID: 23295166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal stromal cells improve cardiac function and left ventricular remodeling in a heart transplantation model.
    Montanari S; Dayan V; Yannarelli G; Billia F; Viswanathan S; Connelly KA; Keating A
    J Heart Lung Transplant; 2015 Nov; 34(11):1481-8. PubMed ID: 26234284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal stroma cells improve hyperglycemia and insulin deficiency in the diabetic porcine pancreatic microenvironment.
    Chang C; Niu D; Zhou H; Zhang Y; Li F; Gong F
    Cytotherapy; 2008; 10(8):796-805. PubMed ID: 18979304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endovenous administration of bone-marrow-derived multipotent mesenchymal stromal cells prevents renal failure in diabetic mice.
    Ezquer F; Ezquer M; Simon V; Pardo F; Yañez A; Carpio D; Conget P
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1354-65. PubMed ID: 19822294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stem cell therapy improves diabetic cardiac autonomic neuropathy and decreases the inducibility of ventricular arrhythmias.
    Wang Y; Xue M; Xuan YL; Hu HS; Cheng WJ; Suo F; Li XR; Yan SH; Wang LX
    Heart Lung Circ; 2013 Dec; 22(12):1018-25. PubMed ID: 23850388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal stem cells transplantation mildly ameliorates experimental diabetic nephropathy in rats.
    Zhou H; Tian HM; Long Y; Zhang XX; Zhong L; Deng L; Chen XH; Li XQ
    Chin Med J (Engl); 2009 Nov; 122(21):2573-9. PubMed ID: 19951572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow mesenchymal stem cells induce angiogenesis and attenuate the remodeling of diabetic cardiomyopathy.
    Zhang N; Li J; Luo R; Jiang J; Wang JA
    Exp Clin Endocrinol Diabetes; 2008 Feb; 116(2):104-11. PubMed ID: 18286426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autologous bone marrow-derived rat mesenchymal stem cells promote PDX-1 and insulin expression in the islets, alter T cell cytokine pattern and preserve regulatory T cells in the periphery and induce sustained normoglycemia.
    Boumaza I; Srinivasan S; Witt WT; Feghali-Bostwick C; Dai Y; Garcia-Ocana A; Feili-Hariri M
    J Autoimmun; 2009 Feb; 32(1):33-42. PubMed ID: 19062254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of bone marrow-derived mesenchymal stem cells on cardiovascular complications in diabetic rats.
    Abdel Aziz MT; El-Asmar MF; Haidara M; Atta HM; Roshdy NK; Rashed LA; Sabry D; Youssef MA; Abdel Aziz AT; Moustafa M
    Med Sci Monit; 2008 Nov; 14(11):BR249-55. PubMed ID: 18971868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal stem cell therapy for heart disease.
    Gnecchi M; Danieli P; Cervio E
    Vascul Pharmacol; 2012 Aug; 57(1):48-55. PubMed ID: 22521741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deferoxamine preconditioning potentiates mesenchymal stem cell homing in vitro and in streptozotocin-diabetic rats.
    Najafi R; Sharifi AM
    Expert Opin Biol Ther; 2013 Jul; 13(7):959-72. PubMed ID: 23536977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of stem cell differentiation in diabetic rats transplanted with bone marrow mesenchymal stem cells.
    Lin P; Chen L; Yang N; Sun Y; Xu YX
    Transplant Proc; 2009 Jun; 41(5):1891-3. PubMed ID: 19545751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human umbilical cord blood-derived mesenchymal stem cells prevent diabetic renal injury through paracrine action.
    Park JH; Hwang I; Hwang SH; Han H; Ha H
    Diabetes Res Clin Pract; 2012 Dec; 98(3):465-73. PubMed ID: 23026513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous administration of bone marrow-derived multipotent mesenchymal stromal cells has a neutral effect on obesity-induced diabetic cardiomyopathy.
    Calligaris SD; Conget P
    Biol Res; 2013; 46(3):251-5. PubMed ID: 24346072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exosomes derived from bone marrow mesenchymal stem cells harvested from type two diabetes rats promotes neurorestorative effects after stroke in type two diabetes rats.
    Venkat P; Zacharek A; Landschoot-Ward J; Wang F; Culmone L; Chen Z; Chopp M; Chen J
    Exp Neurol; 2020 Dec; 334():113456. PubMed ID: 32889008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.